Is this you?
Request access for North Dallas Research Associates with your @ndresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
North Dallas Research Associates
Unclaimed profileIndependent Site · Texas · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall74Recruit51Ops81Sponsor81Ther86
Performance (observed)
Historical trials
371
Completed
192
Terminated/Withdrawn
46
Completion rate
81%
Active now
117
Phase 2
121
Phase 3
224
Realized enrollment
389,726
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
12,179
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
909
States
Texas
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eli Lilly and Company; SWOG Cancer Research Network; Novo Nordisk A/S; Gynecologic Oncology Group
CROs
Clinipace Worldwide; Covance; ICON Clinical Research; PRA Health Sciences
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
samina@ndresearch.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall74
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.